Skip to main content
BESTNMOSDBEST-NMOSD
About NMOSDThe Trial
Team & SitesFAQContactInvestigator Portal
BESTNMOSD

BEST-NMOSD

Comparative Clinical Effectiveness Trial of Rituximab vs. CIS Therapies for Neuromyelitis Optica Spectrum Disorder

Quick Links

  • About NMOSD
  • The Trial
  • Team & Sites
  • FAQ
  • Contact Us
  • Refer a Patient
  • Investigator Portal

Contact & Resources

  • bestnmosd@mgh.harvard.edu
  • ClinicalTrials.gov

Funding

This project is funded by the Patient-Centered Outcomes Research Institute (PCORI). PCORI is an independent, non-profit organization authorized by Congress to fund comparative clinical effectiveness research.

The Sumaira FoundationMass General BrighamHarvard Medical SchoolCharité - Universitätsmedizin Berlin

© 2026 BEST-NMOSD Study Team. All rights reserved.

Funded by the Patient-Centered Outcomes Research Institute (PCORI).